Article Versions Notes

Schräpel C, Kovar L, Selzer D, Hofmann U, Tran F, Reinisch W, Schwab M, Lehr T. External Model Performance Evaluation of Twelve Infliximab Population Pharmacokinetic Models in Patients with Inflammatory Bowel Disease. Pharmaceutics. 2021; 13(9):1368. https://doi.org/10.3390/pharmaceutics13091368

Schräpel, Christina, Lukas Kovar, Dominik Selzer, Ute Hofmann, Florian Tran, Walter Reinisch, Matthias Schwab, and Thorsten Lehr. 2021. "External Model Performance Evaluation of Twelve Infliximab Population Pharmacokinetic Models in Patients with Inflammatory Bowel Disease" Pharmaceutics 13, no. 9: 1368. https://doi.org/10.3390/pharmaceutics13091368

Schräpel, C., Kovar, L., Selzer, D., Hofmann, U., Tran, F., Reinisch, W., Schwab, M., & Lehr, T. (2021). External Model Performance Evaluation of Twelve Infliximab Population Pharmacokinetic Models in Patients with Inflammatory Bowel Disease. Pharmaceutics, 13(9), 1368. https://doi.org/10.3390/pharmaceutics13091368